Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 149


Reduced Expression of Galectin-9 Contributes to a Poor Outcome in Colon Cancer by Inhibiting NK Cell Chemotaxis Partially through the Rho/ROCK1 Signaling Pathway.

Wang Y, Sun J, Ma C, Gao W, Song B, Xue H, Chen W, Chen X, Zhang Y, Shao Q, Wang Q, Zhao L, Liu J, Wang X, Wang H, Zhang Y, Yang M, Qu X.

PLoS One. 2016 Mar 30;11(3):e0152599. doi: 10.1371/journal.pone.0152599. eCollection 2016.


Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.

Su YC, Davuluri GV, Chen CH, Shiau DC, Chen CC, Chen CL, Lin YS, Chang CP.

PLoS One. 2016 Feb 9;11(2):e0148408. doi: 10.1371/journal.pone.0148408. eCollection 2016.


Galectin-3 Plays an Important Role in Innate Immunity to Gastric Infection by Helicobacter pylori.

Park AM, Hagiwara S, Hsu DK, Liu FT, Yoshie O.

Infect Immun. 2016 Mar 24;84(4):1184-93. doi: 10.1128/IAI.01299-15. Print 2016 Apr.


Galectins are human milk glycan receptors.

Noll AJ, Gourdine JP, Yu Y, Lasanajak Y, Smith DF, Cummings RD.

Glycobiology. 2016 Jun;26(6):655-69. doi: 10.1093/glycob/cww002. Epub 2016 Jan 7.


Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells.

Qiao L, Liang N, Xie J, Luo H, Zhang J, Deng G, Li Y, Zhang J.

Mol Med Rep. 2016 Jan;13(1):160-6. doi: 10.3892/mmr.2015.4543. Epub 2015 Nov 10.


Serum Galectin-3: diagnostic value for papillary thyroid carcinoma.

Yılmaz E, Karşıdağ T, Tatar C, Tüzün S.

Ulus Cerrahi Derg. 2015 Apr 9;31(4):192-6. doi: 10.5152/UCD.2015.2928. eCollection 2015.


Serum Galectin-9 Levels Are Associated with Coronary Artery Disease in Chinese Individuals.

Zhu R, Liu C, Tang H, Zeng Q, Wang X, Zhu Z, Liu Y, Mao X, Zhong Y.

Mediators Inflamm. 2015;2015:457167. doi: 10.1155/2015/457167. Epub 2015 Nov 18.


Trichomonas vaginalis Lipophosphoglycan Exploits Binding to Galectin-1 and -3 to Modulate Epithelial Immunity.

Fichorova RN, Yamamoto HS, Fashemi T, Foley E, Ryan S, Beatty N, Dawood H, Hayes GR, St-Pierre G, Sato S, Singh BN.

J Biol Chem. 2016 Jan 8;291(2):998-1013. doi: 10.1074/jbc.M115.651497. Epub 2015 Nov 20.


Clinical implication of the serum galectin-1 expression in epithelial ovarian cancer patients.

Chen L, Yao Y, Sun L, Zhou J, Liu J, Wang J, Li J, Tang J.

J Ovarian Res. 2015 Nov 21;8:78. doi: 10.1186/s13048-015-0206-7.


Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

Vladoiu MC, Labrie M, Létourneau M, Egesborg P, Gagné D, Billard É, Grosset AA, Doucet N, Chatenet D, St-Pierre Y.

Oncotarget. 2015 Dec 1;6(38):40970-80. doi: 10.18632/oncotarget.5403.


Extracellular galectin-3 programs multidrug resistance through Na+/K+-ATPase and P-glycoprotein signaling.

Harazono Y, Kho DH, Balan V, Nakajima K, Hogan V, Raz A.

Oncotarget. 2015 Aug 14;6(23):19592-604.


Glycodendrimers: tools to explore multivalent galectin-1 interactions.

Cousin JM, Cloninger MJ.

Beilstein J Org Chem. 2015 May 12;11:739-47. doi: 10.3762/bjoc.11.84. eCollection 2015.


Sensitive detection of lysosomal membrane permeabilization by lysosomal galectin puncta assay.

Aits S, Kricker J, Liu B, Ellegaard AM, Hämälistö S, Tvingsholm S, Corcelle-Termeau E, Høgh S, Farkas T, Holm Jonassen A, Gromova I, Mortensen M, Jäättelä M.

Autophagy. 2015;11(8):1408-24. doi: 10.1080/15548627.2015.1063871.


Structural Basis Underlying the Binding Preference of Human Galectins-1, -3 and -7 for Galβ1-3/4GlcNAc.

Hsieh TJ, Lin HY, Tu Z, Huang BS, Wu SC, Lin CH.

PLoS One. 2015 May 6;10(5):e0125946. doi: 10.1371/journal.pone.0125946. eCollection 2015.


Glycodendrimers and Modified ELISAs: Tools to Elucidate Multivalent Interactions of Galectins 1 and 3.

Wolfenden M, Cousin J, Nangia-Makker P, Raz A, Cloninger M.

Molecules. 2015 Apr 20;20(4):7059-96. doi: 10.3390/molecules20047059.


Serum galectin-3 as a potential marker for gastric cancer.

Cheng D, Liang B, Li Y.

Med Sci Monit. 2015 Mar 13;21:755-60. doi: 10.12659/MSM.892386.


Overexpression of galectin-7 in mouse epidermis leads to loss of cell junctions and defective skin repair.

Gendronneau G, Sanii S, Dang T, Deshayes F, Delacour D, Pichard E, Advedissian T, Sidhu SS, Viguier M, Magnaldo T, Poirier F.

PLoS One. 2015 Mar 5;10(3):e0119031. doi: 10.1371/journal.pone.0119031. eCollection 2015.


Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.

Pena C, Mirandola L, Figueroa JA, Hosiriluck N, Suvorava N, Trotter K, Reidy A, Rakhshanda R, Payne D, Jenkins M, Grizzi F, Littlefield L, Chiriva-Internati M, Cobos E.

Ann Transl Med. 2014 Sep;2(9):87. doi: 10.3978/j.issn.2305-5839.2014.09.14. Review.


Platelets and galectins.

Schattner M.

Ann Transl Med. 2014 Sep;2(9):85. doi: 10.3978/j.issn.2305-5839.2014.09.02. Review.


Galectin-3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells.

Harazono Y, Kho DH, Balan V, Nakajima K, Zhang T, Hogan V, Raz A.

Oncotarget. 2014 Oct 30;5(20):9992-10001.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk